the prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in hong unexpected increase in positive sputum cultures of non-tuberculous mycobacteria (ntm) was noted in hong kong in 1990 compared to previous years, in contrast to a steady decline in the number of positive cultures of mycobacterium tuberculosis. a retrospective case note study was therefore undertaken to ascertain the clinical importance of the rise in ntm isolates. a representative sample of 183 of the 675 patients with ntm isolates from sputum during 1990 was identified. cases were assigned to ...19957708977
profile of opportunistic infections among hiv-1 infected people in hong determine the spectrum of opportunistic infections in patients with human immunodeficiency virus (hiv-1) infection in hong kong.19957750052
in-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.aminoglycoside-aminocyclitols including streptomycin, kanamycin, capreomycin and amikacin showed considerable activity against mycobacterium tuberculosis, with mics well below their cmax and relatively low mbc/mic ratios. kanamycin, capreomycin and amikacin remained highly active against 'resistant' and 'multidrug-resistant' m. tuberculosis isolates except for some 'multidrug-resistant' isolates which showed complete cross-resistance between streptomycin and the selected 2-deoxystreptamines. gen ...19979249201
comparing the first and second hundred aids cases in hong study the clinical and epidemiological features of the first 200 aids patients in hong kong.19989803809
atypical mycobacterial cutaneous infections in hong kong: 10-year retrospective review the epidemiology of atypical mycobacterial cutaneous infection in hong kong.200616495585
high recurrence rate supports need for secondary prophylaxis in non-hiv patients with disseminated mycobacterium avium complex infection: a multi-center observational study.long-term outcomes in non-hiv immunocompromised patients with disseminated mycobacterium avium complex (dmac) infections are unknown and the need for post-treatment secondary prophylaxis against mac is uncertain in this setting. the objective of this study was to determine the need of continuing secondary anti-mac prophylaxis in non-hiv patients after completing treatment of the primary dmac episode.201626861696
Displaying items 1 - 6 of 6